Vimian Group AB (publ) (VIMIAN.ST) Financials

VIMIAN.ST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 12.7 billion 4.7 billion
Dec. 31, 2025 12.0 billion 4.3 billion
Sept. 30, 2025 12.4 billion 4.7 billion
June 30, 2025 12.7 billion 5.0 billion

VIMIAN.ST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 210.4 million ?
Dec. 31, 2025 539.4 million ?
Sept. 30, 2025 98.4 million ?
June 30, 2025 212.8 million ?

VIMIAN.ST Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 105.2 million
Dec. 31, 2025 207.5 million
Sept. 30, 2025 71.8 million
June 30, 2025 161.6 million

VIMIAN.ST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 555.3 million 2.5 billion 132.2 million
Dec. 31, 2025 594.5 million 2.4 billion 166.5 million
Sept. 30, 2025 567.0 million 2.8 billion 176.9 million
June 30, 2025 752.1 million 3.1 billion 183.9 million

VIMIAN.ST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 5.8 billion
Dec. 31, 2025 5.7 billion
Sept. 30, 2025 5.8 billion
June 30, 2025 5.8 billion

VIMIAN.ST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 36.5 million - - -
Dec. 31, 2025 62.7 million - - -
Sept. 30, 2025 21.0 million - 491.9 million -
June 30, 2025 34.5 million - - -

VIMIAN.ST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.2 billion 1.0 billion
Dec. 31, 2025 1.2 billion 381.6 million
Sept. 30, 2025 1.2 billion 353.7 million
June 30, 2025 1.2 billion 358.8 million

VIMIAN.ST

Price: SEK27.95

52 week price:
24.18
46.00

Earnings Per Share: 0.76 SEK

P/E Ratio: 39.61

Exchange: STO

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 15.9 billion

Links: